Abstract:Alzheimer's disease (AD) is known as a typical neurodegenerative disease, and the pathogenic hallmark is the aggregation and deposition of amyloid-beta peptide (A beta) fibrils and plaque on neuronal cells resulting in cell dysfunction and cell death. One effective approach to preventing and curing AD lies in tuning A beta aggregation and inhibiting the neurotoxicity by using molecular modulators. Peptide breakers and antioxidants are widely used inhibitors to modulate A beta aggregation and neurotoxicity, although less efficiency of single modulators hinders the practical application of these molecules. An integration of different molecular modulators is expected to make use of multiple interactions and modulating sites and therefore synergistically improve the capacity of modulators in inhibiting A beta aggregation. In this work, the concept of a binary peptide-polyphenol binary modulator (A beta-segment KLVFF and (-)-epigallocatechin-3-gallate, KLVFF/EGCG) is proposed, and the synergistic effect of the KLVFF/EGCG modulator is demonstrated for efficient inhibition of A beta aggregation and neurotoxicity. With the aid of thioflavin T fluorescence, circular dichroism spectroscopy, atomic force microscopy, and transmission electron microscopy, the inhibitory effect on A beta 42 fibrillation was determined. Further liquid-state nuclear magnetic resonance spectroscopy and molecular dynamics simulations evidenced the affinity of the KLVFF/EGCG complex to the A beta 42 monomer. Furthermore, a tentative schematic mechanism is also proposed to illustrate the synergistic effect. Besides, the MTT assay and DCFH-DA (2', 7'-dichlorodihydrofluorescein diacetate) test were performed to explore the reduction of A beta 42-induced neurotoxicity by treating with the KLVFF/EGCG complex. The binary inhibitors showed remarkable reduction in A beta 42-induced ROS generation. This work could be beneficial for the designing of potential therapeutic binary modulators and shed light on AD prevention.

Molecular Integrative Study on Inhibitory Effects of Pentapeptides on Polymerization and Cell Toxicity of Amyloid-β Peptide (1–42)

Molecular Integrative Analysis of the Inhibitory Effects of Dipeptides on Amyloid β Peptide 1–42 Polymerization

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

Molecular Simulations of Amyloid Structures, Toxicity, and Inhibition

Impact of Alternating Amino Acid Sequences on Beta-Amyloid-induced Neurotoxicity and Neuroinflammation in Alzheimer's Disease.

A Computational Study of Self-Assembled Hexapeptide Inhibitors Against Amyloid-Β (aβ) Aggregation.

Macromolecular and small-molecule modulation of intracellular Aβ42 aggregation and associated toxicity.

Exploring the Impact of C‐Terminal Based Pentapeptides on the Disassembly of Aβ42 Fibrils

Advances in Alzheimer's Disease-Associated Aβ Therapy Based on Peptide

Advances in Alzheimer’s Disease-Associated Aβ Therapy Based on Peptide

Peptide–Polyphenol (KLVFF/EGCG) Binary Modulators for Inhibiting Aggregation and Neurotoxicity of Amyloid-β Peptide

Atomistic Characterization of Binding Modes and Affinity of Peptide Inhibitors to Amyloid-Β Protein

Multifunctional Peptide-Assembled Micelles For Simultaneously Reducing Amyloid-Beta And Reactive Oxygen Species

Aβ42-binding peptoids as amyloid aggregation inhibitors and detection ligands.

Design of a Molecular Hybrid of Dual Peptide Inhibitors Coupled on AuNPs for Enhanced Inhibition of Amyloid Β‐protein Aggregation and Cytotoxicity

Biomimetic Dendrimer–Peptide Conjugates for Early Multi‐Target Therapy of Alzheimer's Disease by Inflammatory Microenvironment Modulation

Pharmacodynamics in Alzheimer's Disease Model Rats of a Bifunctional Peptide with the Potential to Accelerate the Degradation and Reduce the Toxicity of Amyloid Β-Cu Fibrils.

Self-Assembly Molecular Chaperone to Concurrently Inhibit the Production and Aggregation of Amyloid Β Peptide Associated with Alzheimer’s Disease

Proteomic Analysis Reveals Physiological Activities of Aβ Peptide for Alzheimer's Disease

Inhibition of Alzheimer’s Amyloid Toxicity with a Tricyclic Pyrone Molecule in Vitro and in Vivo

Structural Optimization and Biological Evaluation of Substituted Bisphenol A Derivatives As Beta-Amyloid Peptide Aggregation Inhibitors.